ADVERSE EFFECTS OF OSELTAMIVIR Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012

被引：25
|
作者：
Hoffman, Keith B. [1 ]
Demakas, Andrea [1 ]
Erdman, Colin B. [1 ]
Dimbil, Mo [1 ]
Doraiswamy, P. Murali [2 ,3 ]
机构：
[1] AdverseEvents, Healdsburg, CA 95448 USA
[2] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2013年 / 347卷
关键词：
D O I：
10.1136/bmj.f4656
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Oseltamivir-induced hepatotoxicity: A retrospective analysis of the FDA adverse event reporting system
    Yu, Lurong
    Xiang, Qiumeng
    Liu, Limei
    PLOS ONE, 2025, 20 (02):
  • [2] Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis
    Mark Jones
    Rokuro Hama
    Tom Jefferson
    Peter Doshi
    Drug Safety, 2012, 35 : 1187 - 1188
  • [3] Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis
    Jones, Mark
    Hama, Rokuro
    Jefferson, Tom
    Doshi, Peter
    DRUG SAFETY, 2012, 35 (12) : 1187 - 1188
  • [4] Analysis of Neuropsychiatric Adverse Events in Patients Treated with Oseltamivir in Spontaneous Adverse Event Reports
    Ueda, Natsumi
    Umetsu, Ryogo
    Abe, Junko
    Kato, Yamato
    Nakayama, Yoko
    Kato, Zenichiro
    Kinosada, Yasutomi
    Nakamura, Mitsuhiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (10) : 1638 - 1644
  • [5] Neuropsychiatric and Other Adverse Reactions to Oseltamivir (Tamiflu)
    Brown, J. A.
    Gunja, N.
    Graudins, A.
    CLINICAL TOXICOLOGY, 2010, 48 (03) : 257 - 257
  • [6] Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis Reply
    Toovey, Stephen
    DRUG SAFETY, 2012, 35 (12) : 1188 - 1190
  • [7] Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
    Mao, Wei
    Jiang, Junyan
    Xia, Yanping
    Zhang, Lin
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [8] Adverse effects in Japanese children taking oseltamivir
    不详
    INFECTIONS IN MEDICINE, 2006, 23 (01) : 15 - 15
  • [9] Adverse Effects of Clopidogrel: a Cross Sectional Study of the FDA Adverse Event Reporting System Database
    Al-Saikhan, Fahad
    Ahmad, Nehad
    Abd-Elaziz, Mohamed
    Iqbal, Muhammad Shahid
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (07): : 1388 - 1391
  • [10] The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system
    Wei, Wei
    Huang, Liang
    Bai, Yingtao
    Chang, En
    Liu, Jinfeng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345